Oxford BioMedica (LSE:OXB) Days Payable : 48.62 (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Oxford BioMedica Days Payable?

Oxford BioMedica's average Accounts Payable for the six months ended in Dec. 2023 was £7.64 Mil. Oxford BioMedica's Cost of Goods Sold for the six months ended in Dec. 2023 was £28.69 Mil. Hence, Oxford BioMedica's Days Payable for the six months ended in Dec. 2023 was 48.62.

The historical rank and industry rank for Oxford BioMedica's Days Payable or its related term are showing as below:

LSE:OXB' s Days Payable Range Over the Past 10 Years
Min: 39.55 Med: 61.3 Max: 199.25
Current: 70.56

During the past 13 years, Oxford BioMedica's highest Days Payable was 199.25. The lowest was 39.55. And the median was 61.30.

LSE:OXB's Days Payable is ranked worse than
66.16% of 724 companies
in the Biotechnology industry
Industry Median: 150.695 vs LSE:OXB: 70.56

Oxford BioMedica's Days Payable declined from Dec. 2022 (49.11) to Dec. 2023 (48.62). It may suggest that Oxford BioMedica accelerated paying its suppliers.

Oxford BioMedica Days Payable Historical Data

The historical data trend for Oxford BioMedica's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioMedica Days Payable Chart

Oxford BioMedica Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

56.49

66.10

39.55

48.62

72.02

Oxford BioMedica Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															64.98	48.23	49.11	98.66	48.62

Competitive Comparison of Oxford BioMedica's Days Payable

For the Biotechnology subindustry, Oxford BioMedica's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford BioMedica's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioMedica's Days Payable distribution charts can be found below:

* The bar in red indicates where Oxford BioMedica's Days Payable falls into.

Oxford BioMedica Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Oxford BioMedica's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (13.604	+	6.052)	/	2 )	/	49.812	*	365
=	9.828					/	49.812	*	365
=	72.02

Oxford BioMedica's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (9.234	+	6.052)	/	2 )	/	28.69	*	365 / 2
=	7.643					/	28.69	*	365 / 2
=	48.62

Oxford BioMedica Days Payable Related Terms

Thank you for viewing the detailed overview of Oxford BioMedica's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford BioMedica (LSE:OXB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioMedica PLC (LSE:OXB) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

OXBDF:USA OXBl:UK OXO:Germany

Address

Windrush Court, Transport Way, Oxford, GBR, OX4 6LT

Website

https://www.oxb.com

Oxford BioMedica PLC is a player in the healthcare market in the United Kingdom. As a biopharmaceutical company, it focuses on the field of immunotherapy by managing a platform of technologies for designing gene-based medicines. The company's operating segments include the Platform segment consists of the revenue-generating bioprocessing and process development activities undertaken for third parties. Its Product segment consists of the clinical and preclinical development of in vivo and ex vivo gene and cell therapy products. The company derives the maximum revenue from the Platform segment. Its Platform includes LentiVector, LentiStable, TRiPSystem, SecNuc, Analytics, and others. Geographically, it generates the majority of its revenue from Europe.

Oxford BioMedica (LSE:OXB) Headlines

No Headlines